Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesOption Care Health Inc

Option Care Health Inc

Healthcare Medical Care Facilities
PortfolioPortfolio WatchlistWatchlist
Company price
31.6901 USD 0.04 ( 0.13%)
Last update at 2026-11-09T17:49:00Z
VOLUME
2408427
Market Cap
3522.95M
P/E
18.23

Momentum Score

…

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
31.60
Low
31.73
High
52 Week Price Range
18.01
Low
36.80
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
31.65
Dividend Yield
-
Revenue TTM
5693.52M
Revenue Per Share
36.17
Gross Profit TTM
1085.06M
Debt / Equity
0.96
ROE
16.00%
Net Debt
1040.72M
ROCE
13.18%
Diluted EPS TTM
1.29

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 282.90M 283.60M 358.74M 205.77M 116.49M
Net income 207.59M 211.82M 267.09M 150.56M 139.90M
Selling general administrative 682.45M 630.25M 607.43M 566.12M 525.71M
Gross profit 1020.36M 1012.99M 981.22M 866.92M 779.61M
Reconciled depreciation 70.69M 63.50M 62.20M 65.43M 68.80M
Ebit 346.10M 332.63M 409.99M 240.23M 190.84M
Ebitda 416.79M 396.13M 472.19M 325.01M 252.30M
Depreciation and amortization 70.69M 63.50M 62.20M 84.78M 61.46M
Operating income 337.91M 321.83M 314.60M 240.23M 190.84M
Other operating expenses 5311.61M 4676.37M 3987.73M 3704.50M 3247.80M
Interest expense 63.20M 60.56M 62.22M 53.81M 67.00M
Tax provision 75.31M 71.78M 91.65M 55.21M -23.40M
Net interest income -54.56M -49.03M -51.25M -53.81M -67.00M
Income tax expense 75.31M 71.78M 91.65M 55.21M -23.40M
Total revenue 5649.52M 4998.20M 4302.32M 3944.74M 3438.64M
Total operating expenses 682.45M 691.16M 666.63M 626.69M 588.76M
Cost of revenue 4629.16M 3985.21M 3321.10M 3077.82M 2659.03M
Total other income expense net -55.01M -38.23M 44.15M -34.46M -74.35M
Net income from continuing ops 207.59M 211.82M 267.09M 150.56M 139.90M
Net income applicable to common shares - - - 150.56M 139.90M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 3455.77M 3421.74M 3328.35M 3112.94M 2790.92M
Intangible assets 21.90M 16.99M 335.40M 364.12M 366.02M
Other current assets 87.63M 112.20M 46.24M 98.33M 69.50M
Total liab 2129.38M 2017.51M 1906.68M 1726.83M 1615.03M
Total stockholder equity 1326.39M 1404.24M 1421.67M 1386.10M 1175.89M
Deferred long term liab - - - 22.15M -
Other current liab 158.74M 140.81M 167.52M 139.05M 180.45M
Common stock 0.02M 0.02M 0.02M 0.02M 0.02M
Capital stock 0.02M 0.02M 0.02M 0.02M 0.02M
Retained earnings 876.92M 669.34M 457.51M 190.42M 39.87M
Other liab - - - 31.84M 95.44M
Good will 1606.74M 1540.25M 1540.25M 1533.42M 1477.56M
Other assets - - 0.00M 20.91M 470.13M
Cash 232.62M 412.56M 343.85M 294.19M 119.42M
Total current liabilities 829.35M 780.15M 618.31M 565.35M 459.69M
Current deferred revenue - - - 22.15M -25.09M
Net debt 1040.72M 805.41M 822.56M 789.40M 940.48M
Short term debt 30.78M 28.56M 24.28M 25.38M 25.09M
Short long term debt 6.78M 6.51M 6.00M 6.00M 6.00M
Short long term debt total 1273.35M 1217.97M 1166.41M 1083.58M 1059.90M
Other stockholder equity 445.35M 723.84M 949.16M 1174.50M 1136.45M
Property plant equipment - - - 108.32M 111.53M
Total current assets 1264.97M 1322.63M 1094.26M 994.34M 710.26M
Net tangible assets - - - -489.06M -646.26M
Short term investments - - 9.75M - -
Net receivables 473.57M 409.73M 430.16M 377.54M 338.24M
Long term debt 1154.05M 1104.64M 1056.65M 1058.20M 1059.90M
Inventory 471.15M 388.13M 274.00M 224.28M 183.09M
Accounts payable 639.83M 610.78M 426.51M 378.76M 279.25M
Accumulated other comprehensive income 4.11M 11.05M 14.98M 21.16M -0.45M
Common stock total equity - - - 0.02M 0.02M
Retained earnings total equity - - - 190.42M 39.87M
Treasury stock - - - - -2.40M
Non currrent assets other 422.93M 296.80M 11.27M 90.58M 125.54M
Non current assets total 2190.80M 2099.12M 2234.10M 2118.60M 2080.66M
Capital lease obligations 112.52M 106.82M 103.76M 90.82M 93.58M
Long term debt total - - - 1058.20M 1059.90M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -36.47M -44.35M -108.05M -111.54M
Change to liabilities - - - 101.65M 31.98M
Total cashflows from investing activities -161.08M -36.47M -56.51M -108.05M -111.54M
Net borrowings 44.28M 43.58M -6.00M -6.00M -76.84M
Total cash from financing activities -277.31M -218.21M -265.13M 15.27M -76.87M
Change to operating activities - - - -50.76M 25.98M
Net income 207.59M 211.82M 267.09M 150.56M 139.90M
Change in cash -179.94M 68.72M 49.66M 174.76M 20.16M
Begin period cash flow 412.56M 343.85M 294.19M 119.42M 99.27M
End period cash flow 232.62M 412.56M 343.85M 294.19M 119.42M
Total cash from operating activities 258.45M 323.39M 371.30M 267.55M 208.57M
Issuance of capital stock - - - 0.00M 0.00M
Depreciation 70.69M 63.50M 62.20M 65.43M 68.80M
Other cashflows from investing activities -2.53M -0.86M -2.15M -72.69M -85.91M
Change to inventory -81.47M -114.13M -51.00M -41.01M -22.70M
Change to account receivables -54.59M -32.08M 0.22M -36.89M -4.27M
Sale purchase of stock -309.95M -252.73M -250.26M 20.92M -
Other cashflows from financing activities -8.25M -9.05M -8.87M 21.27M 833.48M
Change to netincome - - - 57.32M -8.93M
Capital expenditures 41.31M 35.61M 41.87M 35.36M 25.63M
Change receivables - - - -36.89M -4.27M
Cash flows other operating - - - -33.81M -1.21M
Cash and cash equivalents changes - - - 174.76M 20.16M
Change in working capital -99.75M -20.25M -21.45M -29.78M -11.37M
Stock based compensation 39.96M 36.14M 30.48M 16.78M 9.57M
Other non cash items 31.52M 19.52M 20.20M 15.36M 32.03M
Free cash flow 217.14M 287.79M 329.43M 232.19M 182.94M

Peer Comparison*

Sector: Healthcare Industry: Medical Care Facilities

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
OPCH
Option Care Health Inc		 0.04
0.13%		 31.69 18.23 11.53 0.62 2.85 0.82 11.35
HCA
HCA Healthcare, Inc.		 -
-%		 504.89 14.27 13.46 1.21 291.34 1.83 8.99
THC
Tenet Healthcare Corporation		 10.62
3.75%		 293.95 10.08 12.66 0.96 4.57 1.43 5.80
FSNUY
Fresenius SE & Co KGaA ADR		 0.27
1.86%		 14.79 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc		 0.29
5.59%		 5.57 62.50 35.97 0.30 2.32 0.16 3.90

Profile*

Option Care Health Inc

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.

3000 Lakeside Drive, Bannockburn, IL, United States, 60015

312 940 2443

https://optioncarehealth.com

8000

Name Title Year Born
Mr. John C. Rademacher CEO, Pres & Director 1967
Mr. Michael H. Shapiro CFO & Sr. VP 1971
Mr. Richard P. Denness Chief Commercial Officer 1967
Mr. Brett Michalak Chief Information Officer NA
Mr. Collin G. Smyser Gen. Counsel & Corp. Sec. NA
Ms. Caroline Budde Sr. VP & Chief Compliance Officer NA
Mr. Mike Bavaro Chief HR & Diversity Officer NA
Mr. Matthew Deans Sr. VP of Bus. Devel. NA
Mr. Christopher Frederick Hartman Chief Growth Officer 1967
Ms. Julie Koenig Sr. VP of Operations NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

GFR
CAD 10.94
+37.96%
MOON
CAD 5.04
+14.17%
FDY
CAD 4.42
+12.18%
UCU
CAD 2.38
+11.21%
PDN
CAD 8.39
+11.13%
DIV
CAD 3.64
-10.57%
TOI
CAD 99.55
-4.99%
BSX
CAD 0.82
-4.65%
CSU
CAD 3367.07
-4.52%
LMN
CAD 26.82
-4.52%

Equity Sectors*

  • Basic Materials

    +5.01%

  • Communication Services

    -0.62%

  • Consumer Cyclical

    +1.25%

  • Consumer Defensive

    +0.10%

  • Energy

    +1.86%

  • Financial Services

    +1.87%

  • Healthcare

    +1.14%

  • Industrials

    +3.75%

  • Real Estate

    +0.53%

  • Technology

    +2.31%

  • Utilities

    +0.99%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…